NANOMEDICINE - THE FUTURE OF CANCER TREATMENT
Patil Anushka Naresh* and Adsul Pravin Ramdas
ABSTRACT
Conventional cancer treatment are limited to surgery, radiation and chemotherapy. Conventional cancer therapies include significant adverse effect. Modern cancer treatments concentrate on precise distribution of the drug to the cancerous tissues and reduce adversity effects on health cells. Researchers are working on improved techniques to accurately distribute chemotherapeutic agents at the molecular level within the tumor tissue. This has led to the utilization of nanotechnology in the treatment of cancer. Nanotechnology is that the science and engineering of controlling interest produce molecular quantities, device with novel chemical, physical and biological properties. Almost every field of biosciences uses nanotechnology and
every one of which have an affected biomedicine. It has ability to alter the present methods to diagnosis and treat cancer. Real progress has been made translating nano-based cancer treatments and diagnosis in the clinic and far more are in development. There are nanoparticles used primarily as nanocarries to deliver cytotoxic drugs into tumor tissue. Use of nanoparticles is predicated on different concepts of pharmacology. Nanomedicine is also used to give multiple drugs at the identical time at the cancer site for an improved cytotoxic effect. They selectively deliver the drugs at cancer because of increased the permeability of blood vessels at the tumor site.
Keywords: Immunotherapy, Adoptive Cell Transfer, Nanocarriers, Nanoshell, Nanomedicines.
[Download Article]
[Download Certifiate]